TriSalus Current Deferred Revenue from 2010 to 2026
| TLSI Stock | 4.80 0.25 5.49% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 12.1 M | Current Value 12.7 M | Quarterly Volatility 25.1 M |
Check TriSalus Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TriSalus Life's main balance sheet or income statement drivers, such as Tax Provision of 7.4 K, Interest Income of 279.1 K or Interest Expense of 3.7 M, as well as many indicators such as Price To Sales Ratio of 4.93, Dividend Yield of 0.0 or Days Sales Outstanding of 47.59. TriSalus financial statements analysis is a perfect complement when working with TriSalus Life Valuation or Volatility modules.
TriSalus | Current Deferred Revenue | Build AI portfolio with TriSalus Stock |
The Current Deferred Revenue trend for TriSalus Life Sciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether TriSalus Life is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest TriSalus Life's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of TriSalus Life Sciences over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. TriSalus Life's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TriSalus Life's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
TriSalus Current Deferred Revenue Regression Statistics
| Arithmetic Mean | (27,128,072) | |
| Geometric Mean | 28,062,078 | |
| Coefficient Of Variation | (92.34) | |
| Mean Deviation | 22,119,427 | |
| Median | (42,796,000) | |
| Standard Deviation | 25,050,551 | |
| Sample Variance | 627.5T | |
| Range | 55.5M | |
| R-Value | 0.80 | |
| Mean Square Error | 244.5T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 3,952,085 | |
| Total Sum of Squares | 10040.5T |
TriSalus Current Deferred Revenue History
About TriSalus Life Financial Statements
Investors use fundamental indicators, such as TriSalus Life's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although TriSalus Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 12.1 M | 12.7 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of TriSalus Life Correlation against competitors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is there potential for Health Care Equipment & Supplies market expansion? Will TriSalus introduce new products? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth 0.574 | Return On Assets | Return On Equity |
Investors evaluate TriSalus Life Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating TriSalus Life's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause TriSalus Life's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, TriSalus Life's market price signifies the transaction level at which participants voluntarily complete trades.